logo
Multimodal therapy in the treatment of breast cancer
Childhood rhabdomyosarcoma with meningeal extension
Radiation therapy and hyperthermia in the treatment of superficial lesions
Survival, prognostic factors, and relapse patterns in uterine cervical carcinoma
Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignancies
Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix
Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix
Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary
Small cell carcinoma of bronchus
A comparison of high-dose continuous and split-course irradiation in non-oat-cell carcinoma of the lung
Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methane-sulfon-m-anisidide) in patients with adenocarcinoma of the pancreas
Measure of blood flow by the multiple radioactive microsphere technique in radiated gastrointestinal tissue
Phase II trial of 10-deaza-aminopterin in patients with advanced colorectal cancer
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors
Phase II study of 9–10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1 H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma
A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract
Preliminary report on phase III RTOG studies of extended-field irradiation in carcinoma of the prostate
4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia
Chromosomes, cancer and radiosensitivity
Let's be realistic about non-oat cell carcinoma of the lung
Isodose Atlas for Use in Radiotherapy
The Handbook of Cancer Immunology
2nd European Conference on Clinical Oncology
Tumor Markers in Cancer Control